QUOTE AND NEWS
TheStreet.com  Feb 20  Comment 
DELAFIELD, Wis. (Stockpickr) -- These three biotech stocks are within range of triggering breakout trades. Star Scientific engages in the development, manufacture, sale, and marketing of nutraceutical dietary supplements and consumer products....
Forbes  Jan 31  Comment 
A federal corruption probe involving a prominent U.S. governor and his wife over potential gifts from a wealthy CEO of a dietary supplement company? So what do I find most interesting? What's in those supplements that facilitated the CEO's wealth?...
MedPage Today  Jan 23  Comment 
(MedPage Today) -- Prominent endocrinologist Paul Ladenson has gotten caught up in a shareholder lawsuit alleging that supplement company Star Scientific misled investors about scientific research.
BusinessWeek  Jan 3  Comment 
The U.S. Food and Drug Administration warns Star Scientific over claims that a pricey dietary supplement can help prevent or heal traumatic brain injury
StreetInsider.com  Jan 2  Comment 
52-Week High: Athersys, Inc. (Nasdaq: ATHX) $2.93. Athersys seeing a strong move above the $2.50 level on volume Thursday. Normally trading about 785,000 shares, roughly 3.6 million have clicked through. There was a positive blog post made...
Benzinga  Dec 31  Comment 
Star Scientific (NASDAQ: STSI) announced that today it has entered into a Letter of Intent for a $15 million Credit Facility with Jonnie R. Williams, Sr. the Company's founder and its former CEO.  The Credit Facility extends through April 15,...
Benzinga  Dec 31  Comment 
Star Scientific, Inc. (NASDAQ: STSI) announced the receipt on December 24, 2013, of a warning letter from the U.S. Food and Drug Administration (FDA) regarding two consumer products, Anatabloc® and CigRx®, which are marketed by the Company. ...
StreetInsider.com  Nov 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Star+Scientific%2C+Inc.+%28STSI%29+Posts+Q3+Loss+of+2cShare/8873064.html for the full story.
Benzinga  Nov 7  Comment 
Star Scientific (NASDAQ: STSI) today announced that the Company has filed its preliminary proxy statement on Form 14A with the Securities and Exchange Commission in preparation for its December 27 annual shareholder meeting. The proxy statement...
StreetInsider.com  Oct 31  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Star+Scientific+%28STSI%29+Reports+Publication+of+Article+on+ASAP+Trial/8831387.html for the full story.




 

Star Scientific is a relatively small and young tobacco company.

The company has a has licensed a patent from Regent Technology (a company controlled by its founder and CEO) for a method of curing tobacco which produces fewer tobacco-specific nitrosamine (TSNAs). It intended to license the technology, but shortly after the patent, RJ Reynolds (RJR) began encouraging its tobacco suppliers to use the technology.[1] It has been involved in the case since then: initially the case was determined by the judge in favor of the defendant RJ Reynolds, but this verdict was reversed and remanded by the United States Court of Appeals for the Federal Circuit.[2] Most recently, in July 2009 a jury verdict was entered in favor of RJ Reynolds, which the company has appealed to the Federal Circuit Court.[3]

The company is also involved in selling dissolvable smokeless tobacco product, marketing a dietary supplement for reducing tobacco cravings called CigRx, and researching treatments for neurological conditions such as Alzheimer's and Parkinson's, particularly using constitutents of tobacco.



References

  1. Star Scientific, Inc. v. RJ Reynolds Tobacco Co., 174 F. Supp. 2d 388 - Dist. Court, D. Maryland v2001.
  2. Star Scientific, Inc. v. RJ Reynolds Tobacco Co., 537 F. 3d 1357 - Court of Appeals, Federal Circuit 2008.
  3. Star Scientific. (2010-03-16). 10-K. SEC.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki